Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression

Journal of Mammary Gland Biology and Neoplasia

Volumn 13, Issue 1, 2008, Pages 93-103

  Wagner, Kay Uwe ^a   Rui, Hallgeir ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Breast cancer initiation; Breast cancer progression; Jak2; Mammary gland development; Prolactin; Stat5

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; GROWTH FACTOR; JANUS KINASE 2; JANUS KINASE 2 INHIBITOR; PROLACTIN; STAT5 PROTEIN; STAT5 PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST DEVELOPMENT; BREAST HYPERPLASIA; CANCER CONTROL; CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CHROMOSOME ABERRATION; DRUG RESEARCH; DRUG SYNTHESIS; ENZYME ACTIVATION; EPITHELIUM CELL; GENE FUNCTION; GENE TARGETING; HUMAN; LACTATION; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NONHUMAN; ONCOGENE; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION;

EID: 40449135440     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-008-9062-z     Document Type: Review

References (102)

1. 1. DS Aaronson CM Horvath 2002 A road map for those who don’t know JAK-STAT Science. 296 5573 1653 1655 12040185 1:CAS:528:DC%2BD38XktlChu7o%3D Aaronson DS, Horvath CM. A road map for those who don’t know JAK-STAT. Science. 2002;296(5573):1653–5.
2. 2. T Kisseleva S Bhattacharya J Braunstein CW Schindler 2002 Signaling through the JAK/STAT pathway, recent advances and future challenges Gene. 285 1–2 1 24 12039028 1:CAS:528:DC%2BD38XitlWmsbg%3D Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285(1–2):1–24.
3. 3. JN Ihle 2001 The Stat family in cytokine signaling Curr Opin Cell Biol. 13 2 211 217 11248555 1:CAS:528:DC%2BD3MXisVCnsro%3D Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol. 2001;13(2):211–7.
4. 4. DE Levy JE Darnell Jr 2002 Stats: transcriptional control and biological impact Nat Rev Mol Cell Biol. 3 9 651 662 12209125 1:CAS:528:DC%2BD38Xmslansrw%3D Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651–62.
5. 5. H Rui RA Kirken WL Farrar 1994 Activation of receptor-associated tyrosine kinase JAK2 by prolactin J Biol Chem. 269 7 5364 5368 7508935 1:CAS:528:DyaK2cXhvVentro%3D Rui H, Kirken RA, Farrar WL. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem. 1994;269(7):5364–8.
6. 6. L DaSilva OM Howard H Rui RA Kirken WL Farrar 1994 Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors J Biol Chem. 269 28 18267 18270 8034567 1:CAS:528:DyaK2cXltVSjtL4%3D DaSilva L, Howard OM, Rui H, Kirken RA, Farrar WL. Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J Biol Chem. 1994;269(28):18267–70.
7. 7. K Sakamoto BA Creamer AA Triplett KU Wagner 2007 The Janus kinase 2 is required for expression and nuclear accumulation of Cyclin D1 in proliferating mammary epithelial cells Mol Endocrinol. 21 8 1877 1892 17519353 1:CAS:528:DC%2BD2sXos12rsrg%3D Sakamoto K, Creamer BA, Triplett AA, Wagner KU. The Janus kinase 2 is required for expression and nuclear accumulation of Cyclin D1 in proliferating mammary epithelial cells. Mol Endocrinol. 2007;21(8):1877–92.
8. 8. H Wakao F Gouilleux B Groner 1994 Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response [published erratum appears in EMBO J 1995 Feb 15;14(4):854–5] EMBO J. 13 9 2182 2191 7514531 1:CAS:528:DyaK2cXlsFSgtr0%3D Wakao H, Gouilleux F, Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response [published erratum appears in EMBO J 1995 Feb 15;14(4):854–5]. EMBO J. 1994;13(9):2182–91.
9. 9. X Liu GW Robinson F Gouilleux B Groner L Hennighausen 1995 Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue Proc Natl Acad Sci USA 92 19 8831 8835 7568026 1:CAS:528:DyaK2MXotVGqsLk%3D Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci USA 1995;92(19):8831–5.
10. 10. MT Nevalainen J Xie L Bubendorf KU Wagner H Rui 2002 Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium Mol Endocrinol. 16 5 1108 1124 11981045 1:CAS:528:DC%2BD38XjsFGhsbw%3D Nevalainen MT, Xie J, Bubendorf L, Wagner KU, Rui H. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium. Mol Endocrinol. 2002;16(5):1108–24.
11. 11. KU Wagner A Krempler AA Triplett Y Qi NM George J Zhu 2004 Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice Mol Cell Biol. 24 12 5510 5520 15169911 1:CAS:528:DC%2BD2cXkvFOqtbw%3D Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, et al. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol. 2004;24(12):5510–20.
12. 12. X Liu GW Robinson L Hennighausen 1996 Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation Mol Endocrinol. 10 12 1496 1506 8961260 1:CAS:528:DyaK28XntlamtLw%3D Liu X, Robinson GW, Hennighausen L. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol. 1996;10(12):1496–506.
13. 13. Y Cui G Riedlinger K Miyoshi W Tang C Li CX Deng 2004 Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation Mol Cell Biol. 24 18 8037 8047 15340066 1:CAS:528:DC%2BD2cXnslCrsLs%3D Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX, et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol. 2004;24(18):8037–47.
14. 14. X Liu GW Robinson KU Wagner L Garrett A Wynshaw-Boris L Hennighausen 1997 Stat5a is mandatory for adult mammary gland development and lactogenesis Genes Dev. 11 2 179 186 9009201 1:CAS:528:DyaK2sXpsVKqsg%3D%3D Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997;11(2):179–86.
15. 15. S Teglund C McKay E Schuetz JM Deursen van D Stravopodis D Wang 1998 Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses Cell. 93 841 850 9630227 1:CAS:528:DyaK1cXjsl2rtbs%3D Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998;93:841–50.
16. 16. MJ LeBaron TJ Ahonen MT Nevalainen H Rui 2007 In vivo response-based identification of direct hormone target cell populations using high-density tissue arrays Endocrinology. 148 3 989 1008 17138649 1:CAS:528:DC%2BD2sXitlWnsrg%3D LeBaron MJ, Ahonen TJ, Nevalainen MT, Rui H. In vivo response-based identification of direct hormone target cell populations using high-density tissue arrays. Endocrinology. 2007;148(3):989–1008.
17. 17. FE Jones T Welte XY Fu DF Stern 1999 ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation J Cell Biol. 147 1 77 88 10508857 1:CAS:528:DyaK1MXmsVCltLc%3D Jones FE, Welte T, Fu XY, Stern DF. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol. 1999;147(1):77–88.
18. 18. AV Kazansky EB Kabotyanski SL Wyszomierski MA Mancini JM Rosen 1999 Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A J Biol Chem. 274 32 22484 22492 10428824 1:CAS:528:DyaK1MXlt1CnsL4%3D Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem. 1999;274(32):22484–92.
19. 19. Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Mol Endocrinol. 2007;21(9):2218–32.
20. 20. ND Horseman W Zhao E Montecino-Rodriguez M Tanaka K Nakashima SJ Engle 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene EMBO J. 16 6926 6935 9384572 1:CAS:528:DyaK1cXisVCitQ%3D%3D Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926–35.
21. 21. CJ Ormandy A Camus J Barra D Damotte B Lucas H Buteau 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse Genes Dev. 11 2 167 178 9009200 1:CAS:528:DyaK2sXpsVKmsg%3D%3D Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 1997;11(2):167–78.
22. 22. C Brisken S Kaur TE Chavarria N Binart RL Sutherland RA Weinberg 1999 Prolactin controls mammary gland development via direct and indirect mechanisms Dev Biol. 210 1 96 106 10364430 1:CAS:528:DyaK1MXjs1Gntro%3D Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol. 1999;210(1):96–106.
23. 23. K Miyoshi JM Shillingford GH Smith SL Grimm KU Wagner T Oka 2001 Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium J Cell Biol. 155 4 531 542 11706048 1:CAS:528:DC%2BD3MXosVKitbg%3D Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, et al. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol. 2001;155(4):531–42.
24. 24. L Hennighausen GW Robinson KU Wagner W Liu 1997 Prolactin signaling in mammary gland development J Biol Chem. 272 12 7567 7569 9119818 1:CAS:528:DyaK2sXitFWgsbk%3D Hennighausen L, Robinson GW, Wagner KU, Liu W. Prolactin signaling in mammary gland development. J Biol Chem. 1997;272(12):7567–9.
25. 25. R Das BK Vonderhaar 1997 Prolactin as a mitogen in mammary cells J Mammary Gland Biol Neoplasia. 2 1 29 39 10887517 1:STN:280:DC%2BD3czksFOhuw%3D%3D Das R, Vonderhaar BK. Prolactin as a mitogen in mammary cells. J Mammary Gland Biol Neoplasia. 1997;2(1):29–39.
26. 26. RA Erwin RA Kirken MG Malabarba WL Farrar H Rui 1995 Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless Endocrinology. 136 8 3512 3518 7628388 1:STN:280:DyaK2MzlsVKjsA%3D%3D Erwin RA, Kirken RA, Malabarba MG, Farrar WL, Rui H. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology. 1995;136(8):3512–8.
27. 27. PM Grimley F Dong H Rui 1999 Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation Cytokine Growth Factor Rev. 10 2 131 157 10743504 1:CAS:528:DyaK1MXmslersrg%3D Grimley PM, Dong F, Rui H. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 1999;10(2):131–57.
28. 28. M Llovera P Touraine PA Kelly V Goffin 2000 Involvement of prolactin in breast cancer: redefining the molecular targets Exp Gerontol. 35 1 41 51 10705038 1:CAS:528:DC%2BD3cXhsFGqt7c%3D Llovera M, Touraine P, Kelly PA, Goffin V. Involvement of prolactin in breast cancer: redefining the molecular targets. Exp Gerontol. 2000;35(1):41–51.
29. 29. X Liu MI Gallego GH Smith GW Robinson L Hennighausen 1998 Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b Cell Growth Differ. 9 9 795 803 9751123 1:CAS:528:DyaK1cXmtVKltbo%3D Liu X, Gallego MI, Smith GH, Robinson GW, Hennighausen L. Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Cell Growth Differ. 1998;9(9):795–803.
30. 30. GB Udy RP Towers RG Snell RJ Wilkins SH Park PA Ram 1997 Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression Proc Natl Acad Sci USA 94 14 7239 7244 9207075 1:CAS:528:DyaK2sXksFOgu7w%3D Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 1997;94(14):7239–44.
31. 31. MI Gallego N Binart GW Robinson R Okagaki KT Coschigano J Perry 2001 Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects Dev Biol. 229 1 163 175 11133161 1:CAS:528:DC%2BD3cXptVygt7k%3D Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, et al. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol. 2001;229(1):163–75.
32. 32. KD Bunting HL Bradley TS Hawley R Moriggl BP Sorrentino JN Ihle 2002 Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5 Blood. 99 2 479 487 11781228 1:CAS:528:DC%2BD38XmslGlsA%3D%3D Bunting KD, Bradley HL, Hawley TS, Moriggl R, Sorrentino BP, Ihle JN. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood. 2002;99(2):479–87.
33. 33. M Kieslinger I Woldman R Moriggl J Hofmann JC Marine JN Ihle 2000 Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation Genes Dev. 14 2 232 244 10652277 1:CAS:528:DC%2BD3cXhtVSht7o%3D Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, Ihle JN, et al. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev. 2000;14(2):232–44.
34. 34. R Moriggl DJ Topham S Teglund V Sexl C McKay D Wang 1999 Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells Immunity. 10 2 249 259 10072077 1:CAS:528:DyaK1MXhs1ymt7c%3D Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity. 1999;10(2):249–59.
35. 35. E Parganas D Wang D Stravopodis DJ Topham JC Marine S Teglund 1998 Jak2 is essential for signaling through a variety of cytokine receptors Cell. 93 385 395 9590173 1:STN:280:DyaK1c3ltVSmtw%3D%3D Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998;93:385–95.
36. 36. H Neubauer A Cumano M Muller H Wu U Huffstadt K Pfeffer 1998 Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis Cell. 93 397 409 9590174 1:CAS:528:DyaK1cXjtFCjtLk%3D Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell. 1998;93:397–409.
37. 37. L Zhao S Hart J Cheng JJ Melenhorst B Bierie M Ernst 2004 Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK J Biol Chem. 279 42 44093 44100 15292206 1:CAS:528:DC%2BD2cXot1ynsrw%3D Zhao L, Hart S, Cheng J, Melenhorst JJ, Bierie B, Ernst M, et al. Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK. J Biol Chem. 2004;279(42):44093–100.
38. 38. JM Shillingford K Miyoshi GW Robinson SL Grimm JM Rosen H Neubauer 2002 Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium Mol Endocrinol. 16 3 563 570 11875116 1:CAS:528:DC%2BD38XitFSisLs%3D Shillingford JM, Miyoshi K, Robinson GW, Grimm SL, Rosen JM, Neubauer H, et al. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol Endocrinol. 2002;16(3):563–70.
39. 39. A Krempler Y Qi AA Triplett J Zhu H Rui KU Wagner 2004 Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice Genesis. 40 1 52 57 15354294 1:CAS:528:DC%2BD2cXptl2lt74%3D Krempler A, Qi Y, Triplett AA, Zhu J, Rui H, Wagner KU. Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice. Genesis. 2004;40(1):52–7.
40. 40. E Iavnilovitch B Groner I Barash 2002 Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis Mol Cancer Res 1 1 32 47 12496367 1:CAS:528:DC%2BD38Xps1yqs7Y%3D Iavnilovitch E, Groner B, Barash I. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 2002;1(1):32–47.
41. 41. M Li X Liu G Robinson U Bar-Peled KU Wagner WS Young 1997 Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution Proc Natl Acad Sci USA 94 7 3425 3430 9096410 1:CAS:528:DyaK2sXisVKns7k%3D Li M, Liu X, Robinson G, Bar-Peled U, Wagner KU, Young WS, et al. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci USA 1997;94(7):3425–30.
42. 42. RD Cardiff 1998 Are the TDLU of the human the same as the LA of mice? J Mammary Gland Biol Neoplasia 3 1 3 5 10819500 1:STN:280:DC%2BD3c3nslOrtQ%3D%3D Cardiff RD. Are the TDLU of the human the same as the LA of mice? J Mammary Gland Biol Neoplasia 1998;3(1):3–5.
43. 43. SR Wellings HM Jensen RG Marcum 1975 An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions J Natl Cancer Inst. 55 2 231 273 169369 1:STN:280:DyaE28%2FgslKhug%3D%3D Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55(2):231–73.
44. 44. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 1:CAS:528:DC%2BD3cXks1CktA%3D%3D Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57–70.
45. 45. I Cotarla S Ren Y Zhang E Gehan B Singh PA Furth 2004 Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers Int J Cancer. 108 5 665 671 14696092 1:CAS:528:DC%2BD2cXmvFWmsw%3D%3D Cotarla I, Ren S, Zhang Y, Gehan E, Singh B, Furth PA. Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers. Int J Cancer. 2004;108(5):665–71.
46. 46. T Li F Sotgia MA Vuolo M Li WC Yang RG Pestell 2006 Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status Am J Pathol 168 6 1998 2013 16723714 1:CAS:528:DC%2BD28XlvVOhsb0%3D Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, et al. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 2006;168(6):1998–2013.
47. 47. DS Park H Lee PG Frank B Razani AV Nguyen AF Parlow 2002 Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade Mol Biol Cell. 13 10 3416 3430 12388746 1:CAS:528:DC%2BD38XotFyrsro%3D Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, et al. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Mol Biol Cell. 2002;13(10):3416–30.
48. 48. EK Sloan KL Stanley RL Anderson 2004 Caveolin-1 inhibits breast cancer growth and metastasis Oncogene 23 7893 7897 15334058 1:CAS:528:DC%2BD2cXotl2ktbs%3D Sloan EK, Stanley KL, Anderson RL. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 2004;23:7893–7.
49. 49. J Li GS Hassan TM Williams C Minetti RG Pestell HB Tanowitz 2005 Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation Cell Cycle. 4 12 1817 1825 16294037 1:CAS:528:DC%2BD28XktVCgsrs%3D Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, et al. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle. 2005;4(12):1817–25.
50. 50. F Sotgia W Schubert RG Pestell MP Lisanti 2006 Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling Cancer Biol Ther. 5 3 292 297 16418573 1:CAS:528:DC%2BD28XntlWku7k%3D 10.4161/cbt.5.3.2390 Sotgia F, Schubert W, Pestell RG, Lisanti MP. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling. Cancer Biol Ther. 2006;5(3):292–7.
51. 51. F Sotgia TM Williams W Schubert F Medina C Minetti RG Pestell 2006 Caveolin-1 deficiency (−/−) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness Am J Pathol. 168 1 292 309 16400031 1:CAS:528:DC%2BD28XhtVKktrs%3D Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, et al. Caveolin-1 deficiency (−/−) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am J Pathol. 2006;168(1):292–309.
52. 52. TM Williams MW Cheung DS Park B Razani AW Cohen WJ Muller 2003 Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice Mol Biol Cell. 14 3 1027 1042 12631721 1:CAS:528:DC%2BD3sXislOqt7g%3D Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, et al. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol Biol Cell. 2003;14(3):1027–42.
53. 53. E Iavnilovitch RD Cardiff B Groner I Barash 2004 Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice Int J Cancer. 112 4 607 619 15382041 1:CAS:528:DC%2BD2cXptlGjsbk%3D Iavnilovitch E, Cardiff RD, Groner B, Barash I. Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice. Int J Cancer. 2004;112(4):607–19.
54. 54. H Yamashita H Iwase T Toyama Y Fujii 2003 Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells Oncogene. 22 11 1638 1652 12642867 1:CAS:528:DC%2BD3sXitFSjt7w%3D Yamashita H, Iwase H, Toyama T, Fujii Y. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Oncogene. 2003;22(11):1638–52.
55. 55. JF Mahler W Stokes PC Mann M Takaoka RR Maronpot 1996 Spontaneous lesions in aging FVB/N mice Toxicol Pathol. 24 6 710 716 8994298 1:STN:280:DyaK2s7kslChsw%3D%3D 10.1177/019262339602400606 Mahler JF, Stokes W, Mann PC, Takaoka M, Maronpot RR. Spontaneous lesions in aging FVB/N mice. Toxicol Pathol. 1996;24(6):710–6.
56. 56. AI Nieto G Shyamala JJ Galvez G Thordarson LM Wakefield RD Cardiff 2003 Persistent mammary hyperplasia in FVB/N mice Comp Med. 53 4 433 438 14524420 1:CAS:528:DC%2BD3sXnsVGgsLc%3D Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD. Persistent mammary hyperplasia in FVB/N mice. Comp Med. 2003;53(4):433–8.
57. 57. LM Wakefield G Thordarson AI Nieto G Shyamala JJ Galvez MR Anver 2003 Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling Comp Med. 53 4 424 432 14524419 1:CAS:528:DC%2BD3sXnsVGgsLY%3D Wakefield LM, Thordarson G, Nieto AI, Shyamala G, Galvez JJ, Anver MR, et al. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med. 2003;53(4):424–32.
58. 58. T Eilon B Groner I Barash 2007 Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females Int J Cancer. 121 9 1892 1902 17640063 1:CAS:528:DC%2BD2sXhtFSjsL7J Eilon T, Groner B, Barash I. Tumors caused by overexpression and forced activation of Stat5 in mammary epithelial cells of transgenic mice are parity-dependent and developed in aged, postestropausal females. Int J Cancer. 2007;121(9):1892–902.
59. 59. MR Ginger MF Gonzalez-Rimbau JP Gay JM Rosen 2001 Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland Mol Endocrinol. 15 11 1993 2009 11682629 1:CAS:528:DC%2BD3MXotFKjtr0%3D Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol. 2001;15(11):1993–2009.
60. 60. KU Wagner GH Smith 2005 Pregnancy and stem cell behavior J Mammary Gland Biol Neoplasia. 10 1 25 36 15886884 Wagner KU, Smith GH. Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia. 2005;10(1):25–36.
61. 61. CA Boulanger KU Wagner GH Smith 2005 Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression Oncogene. 24 4 552 560 15580303 1:CAS:528:DC%2BD2MXltVSgtQ%3D%3D Boulanger CA, Wagner KU, Smith GH. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene. 2005;24(4):552–60.
62. 62. LA Matulka AA Triplett KU Wagner 2007 Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells Dev Biol. 303 1 29 44 17222404 1:CAS:528:DC%2BD2sXhvVGgsbc%3D Matulka LA, Triplett AA, Wagner KU. Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev Biol. 2007;303(1):29–44.
63. 63. KU Wagner CA Boulanger MD Henry M Sgagias L Hennighausen GH Smith 2002 An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal Development. 129 6 1377 1386 11880347 1:CAS:528:DC%2BD38XivFSiu7Y%3D Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development. 2002;129(6):1377–86.
64. 64. MD Henry AA Triplett KB Oh GH Smith KU Wagner 2004 Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice Oncogene. 23 41 6980 6985 15286714 1:CAS:528:DC%2BD2cXnsFaitrg%3D Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene. 2004;23(41):6980–5.
65. 65. RC Humphreys L Hennighausen 1999 Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis Cell Growth Differ. 10 10 685 694 10547072 1:CAS:528:DyaK1MXntFCksLY%3D Humphreys RC, Hennighausen L. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ. 1999;10(10):685–94.
66. 66. S Ren HR Cai M Li PA Furth 2002 Loss of Stat5a delays mammary cancer progression in a mouse model Oncogene. 21 27 4335 4339 12082622 1:CAS:528:DC%2BD38XkslKmt7g%3D Ren S, Cai HR, Li M, Furth PA. Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogene. 2002;21(27):4335–9.
67. 67. SR Oakes FG Robertson JG Kench M Gardiner-Garden MP Wand JE Green 2007 Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions Oncogene. 26 4 543 553 16862169 1:CAS:528:DC%2BD2sXoslSjtg%3D%3D Oakes SR, Robertson FG, Kench JG, Gardiner-Garden M, Wand MP, Green JE, et al. Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions. Oncogene. 2007;26(4):543–53.
68. 68. MT Nevalainen J Xie J Torhorst L Bubendorf P Haas J Kononen 2004 Signal transducer and activator of transcription-5 activation and breast cancer prognosis J Clin Oncol. 22 11 2053 2060 15169792 1:CAS:528:DC%2BD2cXpsVWls7o%3D Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, et al. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol. 2004;22(11):2053–60.
69. 69. LA Matulka K-U Wagner 2005 Models of breast cancer Drug Discov Today 2 1 6 1:CAS:528:DC%2BD2MXhtVKrtb%2FM Matulka LA, Wagner K-U. Models of breast cancer. Drug Discov Today 2005;2:1–6.
70. 70. FE Utama MJ Lebaron LM Neilson AS Sultan AF Parlow KU Wagner 2006 Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice J Endocrinol. 188 3 589 601 16522738 1:CAS:528:DC%2BD28Xjt1KjtLs%3D Utama FE, Lebaron MJ, Neilson LM, Sultan AS, Parlow AF, Wagner KU, et al. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. J Endocrinol. 2006;188(3):589–601.
71. 71. CJ Watson WR Miller 1995 Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts Br J Cancer. 71 4 840 844 7710952 1:CAS:528:DyaK2MXmtF2ktrs%3D Watson CJ, Miller WR. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer. 1995;71(4):840–4.
72. 72. H Yamashita M Nishio Y Ando Z Zhang M Hamaguchi K Mita 2006 Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer Endocr Relat Cancer. 13 3 885 893 16954437 1:CAS:528:DC%2BD28Xhtlequr3M Yamashita H, Nishio M, Ando Y, Zhang Z, Hamaguchi M, Mita K, et al. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer. Endocr Relat Cancer. 2006;13(3):885–93.
73. 73. GL Bratthauer BL Strauss FA Tavassoli 2006 STAT 5a expression in various lesions of the breast Virchows Arch. 448 2 165 171 16133357 1:CAS:528:DC%2BD28XhsVartbs%3D Bratthauer GL, Strauss BL, Tavassoli FA. STAT 5a expression in various lesions of the breast. Virchows Arch. 2006;448(2):165–71.
74. 74. BL Strauss GL Bratthauer FA Tavassoli 2006 STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types Hum Pathol. 37 5 586 592 16647957 1:CAS:528:DC%2BD28XktVOqsrk%3D Strauss BL, Bratthauer GL, Tavassoli FA. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types. Hum Pathol. 2006;37(5):586–92.
75. 75. AS Sultan J Xie MJ LeBaron EL Ealley MT Nevalainen H Rui 2005 Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells Oncogene. 24 5 746 760 15592524 1:CAS:528:DC%2BD2MXnt1WlsQ%3D%3D Sultan AS, Xie J, LeBaron MJ, Ealley EL, Nevalainen MT, Rui H. Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene. 2005;24(5):746–60.
76. 76. JH Gutzman DE Rugowski SE Nikolai LA Schuler 2007 Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context Oncogene. 26 43 6341 6348 17438530 1:CAS:528:DC%2BD2sXhtVKiu7zN Gutzman JH, Rugowski DE, Nikolai SE, Schuler LA. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Oncogene. 2007;26(43):6341–8.
77. 77. I Barash 2006 Stat5 in the mammary gland: controlling normal development and cancer J Cell Physiol. 209 2 305 313 16883580 1:CAS:528:DC%2BD28XhtVClu7nK Barash I. Stat5 in the mammary gland: controlling normal development and cancer. J Cell Physiol. 2006;209(2):305–13.
78. 78. Z Nouhi N Chughtai S Hartley E Cocolakis JJ Lebrun S Ali 2006 Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells Cancer Res. 66 3 1824 1832 16452244 1:CAS:528:DC%2BD28XpsVeksA%3D%3D Nouhi Z, Chughtai N, Hartley S, Cocolakis E, Lebrun JJ, Ali S. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res. 2006;66(3):1824–32.
79. 79. MV Maus SC Reilly CV Clevenger 1999 Prolactin as a chemoattractant for human breast carcinoma Endocrinology. 140 11 5447 5450 10537179 1:CAS:528:DyaK1MXmvFemurk%3D Maus MV, Reilly SC, Clevenger CV. Prolactin as a chemoattractant for human breast carcinoma. Endocrinology. 1999;140(11):5447–50.
80. 80. A Manni C Wright G Davis J Glenn R Joehl P Feil 1986 Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay Cancer Res. 46 4 Pt 1 1669 1672 3948157 1:CAS:528:DyaL28XitVSmurw%3D Manni A, Wright C, Davis G, Glenn J, Joehl R, Feil P. Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay. Cancer Res. 1986;46(4 Pt 1):1669–72.
81. 81. H Yamashita H Iwase 2002 The role of Stat5 in estrogen receptor-positive breast cancer Breast Cancer 9 4 312 318 12459712 Yamashita H, Iwase H. The role of Stat5 in estrogen receptor-positive breast cancer. Breast Cancer 2002;9(4):312–8.
82. 82. H Yamashita M Nishio Y Fujii H Iwase 2004 Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice Cancer Sci. 95 8 662 665 15298729 1:CAS:528:DC%2BD2cXot1Kisb8%3D Yamashita H, Nishio M, Fujii Y, Iwase H. Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice. Cancer Sci. 2004;95(8):662–5.
83. 83. JL Boerner JS Biscardi CM Silva SJ Parsons 2005 Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis Mol Carcinog. 44 4 262 273 16167350 1:CAS:528:DC%2BD2MXhtlWmsrvL Boerner JL, Biscardi JS, Silva CM, Parsons SJ. Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis. Mol Carcinog. 2005;44(4):262–73.
84. 84. AM Weaver CM Silva 2006 Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain Mol Endocrinol. 20 10 2392 2405 16772534 1:CAS:528:DC%2BD28XhtVOht7jN Weaver AM, Silva CM. Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain. Mol Endocrinol. 2006;20(10):2392–405.
85. 85. AM Weaver CM Silva 2007 Signal transducer and activator of transcription 5b (STAT5b): a new target of breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) Breast Cancer Res. 9 6 R79 17997837 Weaver AM, Silva CM. Signal transducer and activator of transcription 5b (STAT5b): a new target of breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6). Breast Cancer Res. 2007;9(6):R79.
86. 86. JL Boerner MA Gibson EM Fox ED Posner SJ Parsons CM Silva 2005 Estrogen negatively regulates EGF-mediated STAT5 signaling in HER family receptor overexpressing breast cancer cells Mol Endocrinol. 19 2660 2670 15976008 1:CAS:528:DC%2BD2MXhtFyjsrbK Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, et al. Estrogen negatively regulates EGF-mediated STAT5 signaling in HER family receptor overexpressing breast cancer cells. Mol Endocrinol. 2005;19:2660–70.
87. 87. S Gass J Harris C Ormandy C Brisken 2003 Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function J Mammary Gland Biol Neoplasia. 8 3 269 285 14973373 Gass S, Harris J, Ormandy C, Brisken C. Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function. J Mammary Gland Biol Neoplasia. 2003;8(3):269–85.
88. 88. RW Clarkson MP Boland EA Kritikou JM Lee TC Freeman PG Tiffen 2006 The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development Mol Endocrinol. 20 3 675 685 16293640 1:CAS:528:DC%2BD28Xit1Snsb0%3D Clarkson RW, Boland MP, Kritikou EA, Lee JM, Freeman TC, Tiffen PG, et al. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol Endocrinol. 2006;20(3):675–85.
89. 89. MJ LeBaron J Xie H Rui 2005 Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer Mol Cancer. 4 1 6 15686596 LeBaron MJ, Xie J, Rui H. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol Cancer. 2005;4(1):6.
90. 90. V Fantl G Stamp A Andrews I Rosewell C Dickson 1995 Mice lacking Cyclin D1 are small and show defects in eye and mammary gland development Genes Dev. 9 19 2364 2372 7557388 1:CAS:528:DyaK2MXos12it78%3D Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C. Mice lacking Cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 1995;9(19):2364–72.
91. 91. P Sicinski JL Donaher SB Parker T Li A Fazeli H Gardner 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast Cell. 82 4 621 630 7664341 1:CAS:528:DyaK2MXnvVWmtLc%3D Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 1995;82(4):621–30.
92. 92. JL Brockman MD Schroeder LA Schuler 2002 PRL activates the Cyclin D1 promoter via the Jak2/Stat pathway Mol Endocrinol. 16 4 774 784 11923474 1:CAS:528:DC%2BD38XivVehurY%3D Brockman JL, Schroeder MD, Schuler LA. PRL activates the Cyclin D1 promoter via the Jak2/Stat pathway. Mol Endocrinol. 2002;16(4):774–84.
93. 93. JL Brockman LA Schuler 2005 Prolactin signals via Stat5 and Oct-1 to the proximal Cyclin D1 promoter Mol Cell Endocrinol. 239 1–2 45 53 15885880 1:CAS:528:DC%2BD2MXlslylsLs%3D Brockman JL, Schuler LA. Prolactin signals via Stat5 and Oct-1 to the proximal Cyclin D1 promoter. Mol Cell Endocrinol. 2005;239(1–2):45–53.
94. 94. C Brisken A Ayyannan C Nguyen A Heineman F Reinhardt J Tan 2002 IGF-2 is a mediator of prolactin-induced morphogenesis in the breast Dev Cell. 3 6 877 887 12479812 1:CAS:528:DC%2BD38XpslClsL4%3D Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, et al. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell. 2002;3(6):877–87.
95. 95. H Ruchatz AM Coluccia P Stano E Marchesi C Gambacorti-Passerini 2003 Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells Exp Hematol. 31 4 309 315 12691918 1:CAS:528:DC%2BD3sXislChtrg%3D Ruchatz H, Coluccia AM, Stano P, Marchesi E, Gambacorti-Passerini C. Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells. Exp Hematol. 2003;31(4):309–15.
96. 96. A Slupianek G Hoser I Majsterek A Bronisz M Malecki J Blasiak 2002 Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis Mol Cell Biol. 22 12 4189 4201 12024032 1:CAS:528:DC%2BD38XktlSmu70%3D Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, et al. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis. Mol Cell Biol. 2002;22(12):4189–201.
97. 97. EJ Baxter LM Scott PJ Campbell C East N Fourouclas S Swanton 2005 Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet. 365 9464 1054 1061 15781101 1:CAS:528:DC%2BD2MXisFGrs7g%3D Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054–61.
98. 98. C James V Ugo JP Couedic Le J Staerk F Delhommeau C Lacout 2005 A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature. 434 7037 1144 1148 15793561 1:CAS:528:DC%2BD2MXjsF2ltbk%3D James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144–8.
99. 99. JW Lee YG Kim YH Soung KJ Han SY Kim HS Rhim 2006 The JAK2 V617F mutation in de novo acute myelogenous leukemias Oncogene. 25 9 1434 1436 16247455 1:CAS:528:DC%2BD28XhvFaisrw%3D Lee JW, Kim YG, Soung YH, Han KJ, Kim SY, Rhim HS, et al. The JAK2 V617F mutation in de novo acute myelogenous leukemias. Oncogene. 2006;25(9):1434–6.
100. 100. C Arnould C Philippe V Bourdon MJ Gr goire R Berger P Jonveaux 1999 The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia Hum Mol Genet. 8 9 1741 1749 10441338 1:CAS:528:DyaK1MXmt1ansLg%3D Arnould C, Philippe C, Bourdon V, Gr goire MJ, Berger R, Jonveaux P. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Hum Mol Genet. 1999;8(9):1741–9.
101. 101. EM Kofoed V Hwa B Little KA Woods CK Buckway J Tsubaki 2003 Growth hormone insensitivity associated with a STAT5b mutation N Engl J Med. 349 12 1139 1147 13679528 1:CAS:528:DC%2BD3sXnsV2jtb8%3D Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med. 2003;349(12):1139–47.
102. 102. V Hwa B Little P Adiyaman EM Kofoed KL Pratt G Ocal 2005 Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b J Clin Endocrinol Metab. 90 7 4260 4266 15827093 1:CAS:528:DC%2BD2MXmtlCiu7g%3D Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, et al. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab. 2005;90(7):4260–6.